Arcutis Biotherapeutics (ARQT) Income Statement (2019 - 2026)
Income Statement report data from Mar 31, 2019 to Mar 31, 2026 for Arcutis Biotherapeutics (ARQT).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||||||||||||||||||||||
Total Revenue | 105M (-17.33%) | 128M (+28.50%) | 99M (+21.74%) | 82M (+27.64%) | 64M (-7.94%) | 69M (+54.96%) | 45M (+45.04%) | 31M (+43.07%) | 22M (+59.42%) | 14M (+66.83%) | 8.11M (+70.02%) | 4.77M (+71.58%) | 2.78M (-6.08%) | 2.96M (+305.48%) | 730K | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses | |||||||||||||||||||||||||||||
Research And Development | 31M (+49.78%) | 20M (+4.34%) | 20M (+0.77%) | 19M (+10.89%) | 18M (+21.13%) | 14M (-25.74%) | 20M (+1.04%) | 19M (-16.59%) | 23M (-2.69%) | 24M (-9.38%) | 26M (+4.04%) | 25M (-28.66%) | 35M (+4.34%) | 34M (-51.41%) | 70M (+82.49%) | 38M (-5.93%) | 41M (-22.72%) | 53M (+29.46%) | 41M (+31.95%) | 31M (+42.26%) | 22M (-20.97%) | 27M (-16.40%) | 33M (+9.10%) | 30M (+19.18%) | 25M (+134.01%) | 11M (-12.87%) | 12M (+71.29%) | 7.21M (+16.29%) | 6.20M |
Selling General And Administrative | 74M (-6.20%) | 79M (+26.57%) | 62M (-9.79%) | 69M (+8.08%) | 64M (+11.09%) | 58M (-2.06%) | 59M (+1.12%) | 58M (+6.17%) | 55M (+12.57%) | 49M (+2.25%) | 48M (+3.57%) | 46M (+7.08%) | 43M (+15.94%) | 37M (+4.37%) | 35M (+28.42%) | 28M (+25.49%) | 22M (+17.51%) | 19M (+13.72%) | 16M (+45.49%) | 11M (-21.66%) | 14M (+115.99%) | 6.69M (+20.32%) | 5.56M (-1.07%) | 5.62M (+61.96%) | 3.47M (+54.91%) | 2.24M (-2.61%) | 2.30M (+74.24%) | 1.32M (+76.00%) | 750K |
Operating Expenses | 114M (+3.03%) | 111M (+22.53%) | 91M (-5.65%) | 96M (+6.35%) | 90M (+14.42%) | 79M (-5.76%) | 84M (+3.56%) | 81M (-0.31%) | 81M (+8.70%) | 75M (-0.43%) | 75M (+4.25%) | 72M (-8.98%) | 79M (+10.73%) | 71M (-32.31%) | 105M (+60.22%) | 66M (+5.11%) | 63M (-12.15%) | 71M (+24.89%) | 57M (+35.65%) | 42M (+16.60%) | 36M (+5.96%) | 34M (-11.07%) | 38M (+7.49%) | 36M (+24.36%) | 29M (+120.55%) | 13M (-11.33%) | 15M (+71.55%) | 8.54M (+22.88%) | 6.95M |
Depreciation And Amortization | - | 550K | - | - | 150K (-65.12%) | 430K | - | - | 170K (-26.09%) | 230K (+15.00%) | 200K (0.00%) | 200K (+11.11%) | 180K (+12.50%) | 160K (0.00%) | 160K (0.00%) | 160K (+6.67%) | 150K (+7.14%) | 140K (+16.67%) | 120K (+20.00%) | 100K (0.00%) | 100K (+150.00%) | 40K (+33.33%) | 30K (0.00%) | 30K (0.00%) | 30K (-50.00%) | 60K | - | - | 10K |
Operating Income | |||||||||||||||||||||||||||||
Operating Income | -9.09M | 18M (+115.59%) | 8.53M | -14.61M (-40.44%) | -24.53M (+221.49%) | -7.63M (-80.47%) | -39.07M (-21.98%) | -50.08M (+58.38%) | -31.62M (-48.31%) | -61.17M (+65.77%) | -36.90M (-44.73%) | -66.76M (-12.46%) | -76.26M (+11.46%) | -68.42M (-34.68%) | -104.75M (+59.12%) | -65.83M (+5.11%) | -62.63M (-12.15%) | -71.29M (+24.89%) | -57.08M (+35.65%) | -42.08M (+16.63%) | -36.08M (+5.93%) | -34.06M (-11.07%) | -38.30M (+7.49%) | -35.63M (+24.36%) | -28.65M (+120.55%) | -12.99M (-11.33%) | -14.65M (+71.55%) | -8.54M (+22.88%) | -6.95M |
Ebit | -9.09M | 18M (+115.59%) | 8.53M | -14.61M (-40.44%) | -24.53M (+221.49%) | -7.63M (-80.47%) | -39.07M (-21.98%) | -50.08M (+58.38%) | -31.62M (-48.31%) | -61.17M (+65.77%) | -36.90M (-44.73%) | -66.76M (-12.46%) | -76.26M (+11.46%) | -68.42M (-34.68%) | -104.75M (+59.12%) | -65.83M (+5.11%) | -62.63M (-12.15%) | -71.29M (+24.89%) | -57.08M (+35.65%) | -42.08M (+16.63%) | -36.08M (+5.93%) | -34.06M (-11.07%) | -38.30M (+7.49%) | -35.63M (+24.36%) | -28.65M (+120.55%) | -12.99M (-11.33%) | -14.65M (+71.55%) | -8.54M (+22.88%) | -6.95M |
EBITDA | -6.83M | 15M (+40.15%) | 11M | -12.51M (-48.69%) | -24.38M (+46.78%) | -16.61M (-52.38%) | -34.88M (-22.23%) | -44.85M (+42.61%) | -31.45M (-48.39%) | -60.94M (+66.05%) | -36.70M (-44.86%) | -66.56M (-12.52%) | -76.09M (+11.47%) | -68.26M (-34.74%) | -104.59M (+59.27%) | -65.67M (+5.11%) | -62.48M (-12.19%) | -71.15M (+24.91%) | -56.96M (+35.68%) | -41.98M (+16.64%) | -35.99M (+5.76%) | -34.03M (-11.08%) | -38.27M (+7.50%) | -35.60M (+24.39%) | -28.62M (+114.38%) | -13.35M (-7.80%) | -14.48M (+74.67%) | -8.29M (+19.28%) | -6.95M |
Other Income / Expenses | |||||||||||||||||||||||||||||
Interest Expense | 4.37M (+45.67%) | 3.00M (-2.28%) | 3.07M (+1.32%) | 3.03M (+1.68%) | 2.98M (-46.31%) | 5.55M (-16.54%) | 6.65M (-11.10%) | 7.48M (0.00%) | 7.48M (-3.61%) | 7.76M (+2.65%) | 7.56M (+2.86%) | 7.35M (+4.40%) | 7.04M (+1.73%) | 6.92M (+41.22%) | 4.90M (+145.00%) | 2.00M (+8.70%) | 1.84M | - | - | - | - | - | - | - | - | - | - | - | - |
Net Interest Income | - | - | - | - | - | 7.48M | - | - | -7.48M (-3.61%) | -7.76M (+2.65%) | -7.56M (+2.86%) | -7.35M (+4.40%) | -7.04M (+1.88%) | -6.91M (+41.02%) | -4.90M (+145.00%) | -2.00M (+8.70%) | -1.84M | - | - | - | - | - | - | - | - | - | - | - | - |
Other Non Operating Income | -20.00K | 440K (-78.43%) | 2.04M (-2.86%) | 2.10M (+1005.26%) | 190K (+280.00%) | 50K (-98.80%) | 4.18M (-20.08%) | 5.23M (+29.46%) | 4.04M | -730.00K | 2.72M (-12.82%) | 3.12M (-2.80%) | 3.21M (-44.85%) | 5.82M (+200.00%) | 1.94M (+361.90%) | 420K (+200.00%) | 140K (-17.65%) | 170K (+70.00%) | 100K (+42.86%) | 70K (+75.00%) | 40K (-95.88%) | 970K (+870.00%) | 100K (-54.55%) | 220K (-65.63%) | 640K (-43.86%) | 1.14M (+570.59%) | 170K (-32.00%) | 250K (-13.79%) | 290K |
Net Income | |||||||||||||||||||||||||||||
Income Tax Expense | 90K (-80.85%) | 470K (+487.50%) | 80K (-76.47%) | 340K (+21.43%) | 280K (-12.50%) | 320K | - | - | 320K (+255.56%) | 90K (-97.02%) | 3.02M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income From Continuing Operations | -11.29M | 17M (+134.82%) | 7.41M | -15.89M (-36.59%) | -25.06M (+132.25%) | -10.79M (-74.03%) | -41.54M (-20.62%) | -52.33M (+47.91%) | -35.38M (-46.62%) | -66.28M (+48.08%) | -44.76M (-36.95%) | -70.99M (-11.37%) | -80.10M (+11.22%) | -72.02M (-33.14%) | -107.71M (+59.78%) | -67.41M (+4.80%) | -64.32M (-9.83%) | -71.33M (+25.18%) | -56.98M (+35.63%) | -42.01M (+16.56%) | -36.04M (+5.84%) | -34.05M (-10.86%) | -38.20M (+7.88%) | -35.41M (+26.42%) | -28.01M (+122.83%) | -12.57M (-13.19%) | -14.48M (+74.67%) | -8.29M (+24.47%) | -6.66M |
Net Income | -11.29M | 17M (+134.82%) | 7.41M | -15.89M (-36.59%) | -25.06M (+132.25%) | -10.79M (-74.03%) | -41.54M (-20.62%) | -52.33M (+47.91%) | -35.38M (-46.62%) | -66.28M (+48.08%) | -44.76M (-36.95%) | -70.99M (-11.37%) | -80.10M (+11.22%) | -72.02M (-33.14%) | -107.71M (+59.78%) | -67.41M (+4.80%) | -64.32M (-9.83%) | -71.33M (+25.18%) | -56.98M (+35.63%) | -42.01M (+16.56%) | -36.04M (+5.84%) | -34.05M (-10.86%) | -38.20M (+7.88%) | -35.41M (+26.42%) | -28.01M (+122.83%) | -12.57M (-13.19%) | -14.48M (+74.67%) | -8.29M (+24.47%) | -6.66M |
Comprehensive Income Net Of Tax | -11.76M (-27.32%) | -16.18M | 7.38M | -15.78M (-37.36%) | -25.19M (-82.01%) | -140.05M (+244.02%) | -40.71M (-22.44%) | -52.49M (+47.78%) | -35.52M (-86.39%) | -261.05M (+484.53%) | -44.66M (-36.98%) | -70.87M (-10.78%) | -79.43M (-74.57%) | -312.29M (+189.02%) | -108.05M (+59.74%) | -67.64M (+3.92%) | -65.09M (-68.50%) | -206.61M (+262.73%) | -56.96M (+35.33%) | -42.09M (+16.92%) | -36.00M (-73.47%) | -135.68M (+255.18%) | -38.20M (+7.82%) | -35.43M (+26.58%) | -27.99M (-33.36%) | -42.00M (+190.06%) | -14.48M (+74.67%) | -8.29M (+24.47%) | -6.66M |